Flexion Therapeutics (FLXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | FLXN | KALV | ALT | ||
Company | Flexion Therapeutics | Kalvista Pharmaceuticals Inc | Altimmune Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 9.14 | 11.00 | 6.35 | ||
High | 9.23 | 11.40 | 6.73 | ||
Low | 9.12 | 10.92 | 6.31 | ||
Last | 9.12 | 11.23 | 6.54 | ||
Change | -0.02 | +0.22 | +0.15 | ||
% Change | -0.22% | +2.00% | +2.35% | ||
Volume | 18,723,200 | 134,892 | 2,224,258 | ||
20-Day Average Volume | 2,000,190 | 326,958 | 2,943,000 | ||
Previous Close | 9.14 | 11.01 | 6.40 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 9.24 | 11.36 | 7.70 | ||
20-Day Raw Stochastic | 6.06% | 54.76% | 7.04% | ||
20-Day Relative Strength | 62.41% | 45.86% | 37.97% | ||
Weighted Alpha | -43.65 | +3.47 | -23.65 | ||
Today's Opinion | 56% Buy | 8% Sell | 24% Sell | ||
Previous Opinion | 56% Buy | 24% Sell | 24% Sell | ||
Last Month's Opinion | 24% Buy | 24% Buy | 72% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -0.76% since 11/11/21 | +0.67% since 04/23/24 | -14.00% since 04/23/24 | ||
Low | 9.12 on 11/18/21 | 10.10 on 04/25/24 | 6.28 on 04/29/24 | ||
High | 9.23 on 11/12/21 | 11.40 on 04/30/24 | 7.75 on 04/24/24 | ||
1-Month | |||||
%Chg | -2.04% since 10/18/21 | -4.85% since 03/28/24 | -36.05% since 03/28/24 | ||
Low | 9.10 on 11/10/21 | 10.10 on 04/25/24 | 6.28 on 04/29/24 | ||
High | 9.43 on 10/22/21 | 12.26 on 04/11/24 | 11.01 on 04/01/24 | ||
3-Month | |||||
%Chg | +92.00% since 08/18/21 | -23.80% since 01/30/24 | -33.57% since 01/30/24 | ||
Low | 4.30 on 08/20/21 | 10.10 on 04/25/24 | 6.28 on 04/29/24 | ||
High | 9.89 on 10/11/21 | 16.88 on 02/01/24 | 14.84 on 02/28/24 | ||
6-Month | |||||
%Chg | +7.93% since 05/18/21 | +40.71% since 10/30/23 | +172.38% since 10/30/23 | ||
Low | 4.30 on 08/20/21 | 7.21 on 11/13/23 | 2.32 on 11/13/23 | ||
High | 9.89 on 10/11/21 | 16.88 on 02/01/24 | 14.84 on 02/28/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 458,927 | 464,490 | 453,373 | ||
Shares Outstanding, K | 50,321 | 42,188 | 70,895 | ||
Annual Sales | 85,550,000 | 0 | 430,000 | ||
Annual Net Income | -113,710,000 | -92,910,000 | -88,450,000 | ||
Last Quarter Sales | 28,180,000 | 0 | 40,000 | ||
Last Quarter Net Income | -22,210,000 | -29,030,000 | -31,640,000 | ||
60-Month Beta | 1.53 | 0.88 | 0.05 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A on 11/12/21 | -0.84 on 03/11/24 | -0.33 on 03/27/24 | ||
Latest Earnings Date | 11/17/21 | 03/14/24 | 05/09/24 | ||
Most Recent Dividend | N/A | N/A | 2.910 on 02/06/17 | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |